Trince Bio, a spinoff from @UGent developing groundbreaking technology to deliver functional molecules into living cells for faster treatment, has been selected as one of only four @Nature's The Spinoff Prize finalists. #Excellence#Innovation#Proud
https://t.co/sp5iS6I9qq
@digistain, @saliva_direct, @TrinceBio and Tezcat Biosciences have made it to the final of the #SpinoffPrize 2024 for turning high-quality scientific research into real-world solutions. Find out who wins the €30,000 prize at @FutureInsight. Learn more: https://t.co/Pjilj9avQP
Het wetenschappelijk vakblad @Nature nomineert UGent-spin-off @TrinceBio🧬als finalist voor haar prestigieuze Spinoff Prize! Proficiat Kevin Braeckmans @UGent_Pharma 👏
Lees meer👉https://t.co/1SV0rUPGGC